Crowdfunding
An Aparthotel with Innovative Features Raises Capital with Equity Crowdfunding
The round has a minimum target of €200,000 (to date already exceeded) for a pre-money valuation of €1.5 million. In addition, the deadline for the projected sale of the aparthotel has already been set at 12/31/2026. By this date, the entire structure is expected to be sold and the partners will return their capital in addition to an estimated gross ROI of 49%.
An aparthotel that features the idea of “sharing” and “demolecularization” of ownership, whereby being a member is equivalent to owning a piece of a physical real estate object. An innovative real estate project that will be put to income in the first few years and then sold.
This is Quantum 1, a new project that has launched an equity crowdfunding campaign on CrowdFundMe and which, precisely, offers each new partner to become the owner of a share in an aparthotel in Milan with an innovative concept.
Read more about the Quantum 1 aparthotel and its recent equity crowdfunding, and find the latest business news of the day with the Born2Invest mobile app.
The Quantum project, an innovative aparthotel formula
Quantum 1 is the first in a series of properties that will be purchased, redeveloped, and put into income with the aparthotel formula, to accommodate a wide target of customers (workers, university students, etc.). The idea is to create a new model of automated and modern residential accommodation that stands out from the rest of the market.
One example is the partnership agreement with Homeniscent, a company specializing in smart-homes, thanks to which aparthotels will be equipped with, among other things, technologies for monitoring consumption and sensors for presence, humidity, and window opening. They will also offer coworking services, electric mobility, and gyms.
The preliminary agreement for the first property, Quantum 1, has already been finalized, priced at a discount to the neighborhood average. The property, of about 400sqm commercial, is located in Milan, on Via Broglio, a short walk from the Milan Polytechnic, which attracts more than 40,000 students each year, and from the Bovisa railway junction, already the subject of a major redevelopment project called MoLeCoLa by ParkAssociati, which will give new impetus to the entire neighborhood with a positive impact on the price per sqm of properties in the area.
The masterplan, developed by the team led by Park Associati for an area of more than 90,000 sq. m., will be in front of where the first ApartHotel QUANTUM 1 is to be built. The property is located near the Bovisa node and within walking distance.
The equity crowdfunding campaign
The round has a minimum target of €200,000 (to date already exceeded) for a pre-money valuation of €1.5 million. In addition, the deadline for the projected sale of the aparthotel has already been set at 12/31/2026. By this date, the entire structure is expected to be sold and the partners will return their capital in addition to an estimated gross ROI of 49%.
The project is made possible by a team with high industry expertise: in fact, the founders are Andrea Maffi, former founder of Trusters, and Stefano Bettanin, former founder of Rentopolis (a medium- and short-term rental manager).
In an interview on Startups Wallet, Stefano Bettanin recounted the genesis of the project, “We noticed that a phenomenon called cohousing or coliving is gaining momentum. Tenants, guests or tenants are increasingly looking for a property with precise and certain characteristics. They are therefore opting for a package that allows them to be much more flexible when moving in and out of an apartment. In fact, it is really rare for a person today to stay so many years in the same apartment since the world changes so rapidly, and this causes everyone’s needs and prospects to change just as quickly.”
Quantum has already raised about €400,000 offline and has regularized the technical and urban planning documentation along with the executive documentary part.
__
(Featured image by jeanvdmeulen via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech2 weeks ago
Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA
-
Cannabis5 days ago
Legal Sale of Cannabis in Germany: Pilot Projects in Frankfurt and Hanover
-
Biotech2 weeks ago
Dijon Biotech Company Inventiva Raises 348 Million to Complete Its Phase III
-
Markets3 days ago
Spanish Companies Welcome the End of Trade Restrictions with Algeria with Relief and Caution